Stefanie L. Groenland
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Feasibility and efficacy of therapeutic drug monitoring of abiraterone in metastatic castration resistant prostate cancer patients.
Journal: British journal of cancer
Published: September 27, 2024
Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology - an analysis of the closed cohorts of a multicentre prospective study.
Journal: British journal of cancer
Published: April 15, 2024
Exposure-response analyses of BRAF- and MEK-inhibitors dabrafenib plus trametinib in melanoma patients.
Journal: Cancer chemotherapy and pharmacology
Published: December 28, 2022
Feasibility of therapeutic drug monitoring of sorafenib in patients with liver or thyroid cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 01, 2022
Exposure-Response Analysis of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients in a Real-Life Setting.
Journal: Pharmaceutical research
Published: March 03, 2022
Ritonavir-Boosted Exposure of Kinase Inhibitors: an Open Label, Cross-over Pharmacokinetic Proof-of-Concept Trial with Erlotinib.
Journal: Pharmaceutical research
Published: January 03, 2022
Therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 15, 2021
Exposure-response analyses of cabozantinib in patients with metastatic renal cell cancer.
Journal: BMC cancer
Published: November 16, 2021
Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol.
Journal: Cancers
Published: November 10, 2021
Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 06, 2021
Effects of the Moderate CYP3A4 Inhibitor Erythromycin on the Pharmacokinetics of Palbociclib: A Randomized Crossover Trial in Patients With Breast Cancer.
Journal: Clinical pharmacology and therapeutics
Published: July 13, 2021
Last Updated: 09/26/2026